Combined CTC and CAM-L assessment further refined risk stratification.<h4>Conclusions</h4>Dynamic monitoring of CTCs and CAM-Ls provides actionable prognostic information in metastatic NSCLC. This evidence concerns the gene CAMLG and non-small cell lung carcinoma.